Matrix Metalloproteinase 2
"Matrix Metalloproteinase 2" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A secreted endopeptidase homologous with INTERSTITIAL COLLAGENASE, but which possesses an additional fibronectin-like domain.
| Descriptor ID |
D020778
|
| MeSH Number(s) |
D08.811.277.656.300.480.205.352 D08.811.277.656.300.480.252.420 D08.811.277.656.300.480.525.700.150 D08.811.277.656.675.374.205.352 D08.811.277.656.675.374.252.420 D08.811.277.656.675.374.525.700.150 D12.644.276.848.150 D12.776.467.836.150
|
| Concept/Terms |
Matrix Metalloproteinase 2- Matrix Metalloproteinase 2
- Metalloproteinase 2, Matrix
- 72-kDa Gelatinase
- 72 kDa Gelatinase
- Gelatinase, 72-kDa
- 72-kDa Type IV Collagenase
- 72 kDa Type IV Collagenase
- MMP-2 Metalloproteinase
- MMP 2 Metalloproteinase
- Metalloproteinase, MMP-2
- Gelatinase A
- MMP2 Metalloproteinase
- Metalloproteinase, MMP2
- Matrix Metalloproteinase-2
|
Below are MeSH descriptors whose meaning is more general than "Matrix Metalloproteinase 2".
Below are MeSH descriptors whose meaning is more specific than "Matrix Metalloproteinase 2".
This graph shows the total number of publications written about "Matrix Metalloproteinase 2" by people in this website by year, and whether "Matrix Metalloproteinase 2" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2010 | 0 | 1 | 1 |
| 2016 | 1 | 2 | 3 |
| 2018 | 0 | 2 | 2 |
| 2023 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Matrix Metalloproteinase 2" by people in Profiles.
-
Predictive Value of Serum Biomarkers for Response of Limited-Stage AIDS-Associated Kaposi Sarcoma to Antiretroviral Therapy With or Without Concomitant Chemotherapy in Resource-Limited Settings. J Acquir Immune Defic Syndr. 2023 10 01; 94(2):165-173.
-
Helix aspersa maxima mucus exhibits antimelanogenic and antitumoral effects against melanoma cells. Biomed Pharmacother. 2018 May; 101:871-880.
-
Nesfatin-1 and visfatin expression is associated with reduced atherosclerotic disease risk in patients with rheumatoid arthritis. Peptides. 2018 04; 102:31-37.
-
Apelin concentrations are associated with altered atherosclerotic plaque stability mediator levels and atherosclerosis in rheumatoid arthritis. Atherosclerosis. 2017 01; 256:75-81.
-
In Silico prediction of the molecular basis of ClTx and AaCTx interaction with matrix metalloproteinase-2 (MMP-2) to inhibit glioma cell invasion. J Biomol Struct Dyn. 2017 Oct; 35(13):2815-2829.
-
Omentin concentrations are independently associated with those of matrix metalloproteinase-3 in patients with mild but not severe rheumatoid arthritis. Rheumatol Int. 2017 Jan; 37(1):3-11.
-
Impact of aldosterone receptor blockade on the deleterious cardiac effects of adrenergic activation in hypertensive rats. J Cardiovasc Pharmacol. 2010 Aug; 56(2):203-11.